Abstract
Our understanding of the mechanisms by which systemic diseases lead to alterations in renal function must rest on profound knowledge of normal physiology. In Volume 1 of this series, an attempt was made to employ three schemes which would allow us to predict, treat, or correct the renal manifestations of systemic illness. The schemes were based on the idea that composition changes in blood or alterations in the volume of the fluid compartments of the body inevitably affect the kidney. The schemes also took into consideration that the clinical manifestations of vascular and tubular disease will have their genesis depending on which part of the kidney (cortex versus medulla) is principally involved.1
Keywords
- Multiple Myeloma
- Plasma Renin Activity
- Hemolytic Uremic Syndrome
- Alcoholic Liver Disease
- Thrombotic Thrombocytopenic Purpura
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Martinez-Maldonado, M., 1981, The kidney in systemic disease: Pathophysiological schemes and analysis of two diseases (multiple myeloma and diabetes mellitus), in: Contemporary Nephrology, Volume 1 (S. Klahr and S. G. Massry, eds.), Plenum Publishing Corp., New York, p. 477.
Chidsey, C. A., Harrison, D. C., and Braunwald, E., 1962, Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure, N. Engl. J. Med. 267:650.
Kramer, R. S., Mason, D. T., and Braunwald, E., 1968, Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion, Circulation 38:629.
Merril, A. J., Harrison, J. L., and Brannon, E. D., 1946, Concentration of renin in renal venous blood in patients with chronic heart failure, Am. J. Med. 1:468.
Vandongen, R. and Gordon, R. D., 1970, Plasma renin in congestive heart failure in man, Med. J. Aust. 1:215.
Genest, J., Granger, P., de Champlain, J., and Boucher, R., 1968, Endocrine factors in congestive heart failure, Am. J. Cardiol. 22:35.
Haddy, F. J., Molnar, J. I., Borden, C. W., and Texter, E. C., Jr., 1962, Comparison of direct effects of angiotensin and other vasoactive agents on small and large blood vessels in several vascular beds, Circulation 25:239.
Zelis, R. and Mason, D. T., 1970, Compensatory mechanisms in congestive heart failure—the role of the peripheral resistance vessels, N. Engl. J. Med. 282:962.
Ng, K. K. F. and Vane, J. R., 1967, Conversion of angiotensin I to angiotensin II. Nature 215:762.
Schor, N., Ichikawa, I., and Brenner, B. M., 1981, Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat, Kidney Int. 20:442.
Brenner, B. M., Badr, K. R., Schor, N., and Ichikawa, I., 1980, Hormonal influences on glomerular filtration, Miner. Electrol. Metab. 4:49.
Ichikawa, I., Miele, J. F., and Brenner, B. M., 1979, Reversal of renal cortical actions of angiotensin II by verapamil and manganese, Kidney Int. 16:137.
Nascimento, L., Ayala, J. M., Baquero, R. A., and Martínez-Maldonado, M., 1979, Renin release by diuretics, J.Phar. Exp. Ther. 208:522.
Davis, R., Ribner, S., Keung, E., Sonnenblick, E. H., and Lejemtel, H., 1979, Treatment of chronic congestive heart failure with Captopril, and oral inhibitor or angiotensin-converting enzyme, N. Engl. J. Med. 301(3): 117.
Dzau, V. J., Colucci, W. S., Williams, G. H., Curfman, G., Meggs, L., and Hollenberg, N. K., 1980, Sustained effectiveness of converting-enzyme in inhibition of patients with severe congestive heart failure, N. Engl. J. Med. 302(25):1373.
Watkins, L., Jr., Burton, J. A., Haber, E., Cant, J. R., Smith, F. W., and Barger, A. D., 1976, The renin-angiotensin-aldosterone system in congestive heart failure in conscious dogs, J.Clin. Invest. 57:1606.
Johnson, J. A. and Davis, J. O., 1976, Effects of an angiotensin II analog on blood pressure and adrenal steroid secretion in dogs with thoracic caval constriction, Physiologist 19:184.
Morris, B. J., Davis, J. O., Zatzman, M. L., and Williams, G. M., 1977, The renin-angiotensin aldosterone system in rabbits with congestive heart failure produced by aortic constriction, Circ. Res. 40:275.
Freeman, R. J., Davis, J. O., Williams, G. M., DeForrest, J. M., Seymour, A. A., and Rowe, B. P., 1979, Effects of oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs, Circ. Res. 45:440.
Cohn, J. N., 1980, Progress in vasodilator therapy for heart failure, N. Engl. J. Med. 302(25): 1414.
Packer, M., Meiler, J., Medina, N., Gorling, R., and Herman, M.V., 1980, Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure, N. Engl. J. Med. 303(5):250.
Franciosa, J. A. and Cohn, J. N., 1981, Effects of minoxidil on hemodynamics in patients with congestive heart failure, Circulation 63(3):652.
Ferris, T. F. and Bay, W. H., 1978, Idiopathic edema, in: Contemporary Issues in Nephrology, Volume 1 (B. M. Brenner and J. H. Stein, eds.) Churchill-Livingstone, New York, p. 131.
Skorecki, K. L. and Brenner, B. M., 1982, Body fluid homeostasis in congestive heart failure and cirrhosis with ascites, Am. J. Med. 72:323.
Papper, S., 1978, Renal failure in cirrhosis, in: The Kidney in Liver Disease (M. Epstein, ed.), Elsevier North-Holland, New York, p. 91.
Epstein, M., Berk, D. P., Hollenberg, N. K., Adams, D. F., Chalmer, T. C., Abrams, H. L., and Merrill, J. P., 1970, Renal failure in the patient with cirrhosis. The role of active vasoconstriction, Am. J. Med. 49:17.
Arroyo, V., Bosch, J., Gaya-Beltran, J., Kravetz, D., Estrada, L., Rivera, F., and Rodés, J., 1981, Plasma renin activity and urinary sodium excretion as prognostic indicator in nanozotemic cirrhosis with ascites, Ann. Intern. Med. 94:198.
Schroeder, E. T. and Anderson, G. H., Jr., 1978, Relation of the renin—angiotensin system to hemodynamic abnormalities in cirrhosis: Studies using blockade of angiotensin II, in: The Kidney in Liver Disease (M. Epstein, ed.), Elsevier North-Holland, New York.
Schroeder, E. T., Anderson, G. H., Goldman, S. H., and Streeten, D. H. P., 1979, Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis, Kidney Int. 9:511.
Schroeder, E. T., Numann, P. J., and Chamberlain, B. E., 1970, Functional renal failure in cirrhosis. Recovery after portacaval shunt, Ann. Intern. Med. 79:923.
Schroeder, E. T., Anderson, G. H., Smulyan, H., Numann, P. G., and Hall, R. C., 1976, Effects of portacaval shunt (PCS) or peritoneal jugular conduit (PJC) on renal function and the renin system in hepatorenal syndrome (HRS) (abstract). Kidney Int. 10:510.
Boyer, T. D., Zia, P., and Reynolds, T. B., 1979, Effect of indomethacin and prostaglandin A on renal function and plasma renin activity in alcoholic liver disease, Gastroenterology 77:215.
Nascimento, L., Fiallo, A. J., Negron, M. T., Cruz, N., Ayala, J. M., Baquero, R., and Martínez-Maldonado, M., 1979, Action of indomethacin on furosemide-induced renin release in the dog and the rat, J. Pharm. Exp. Ther. 210:147.
Nascimento, L., Figueroa, J., Fiallo, A., Martínez, R., and Martinez-Maldonado, M., 1979, Alterations in renin release by PGE2 and acetylcholine indomethacin-treated dogs, Renal Physiol. 2:311.
Kent-Keeton, T. and Campbell, W. B., 1981, The pharmacologic alterations of renin release, Pharm. Rev. 31:81.
Zipser, R., Hoetz, J. C., Speckart, P. F., Zia, P. K., and Horton, R., 1979, Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease, J.Clin. Endocrinol. Metab. 48:895.
Benabe, J. E. and Martinez-Maldonado, M., 1978, Hypercalcemic nephropathy, Arch. Intern. Med. 138:777.
Martinez-Maldonado, M. and Garcia, A., 1983, Disorders of calcium metabolism—Hypo- and hypercalcemia, in: Handbook of Renal Therapeutics (M. Martinez-Maldonado, ed.), Plenum Publishing Corp., New York, p. 57.
Marone, C., Beretta-Piccoli, C., and Weidmann, P., 1980, Acute hypercalcemic hypertension in man: Role of hemodynamics, catecholamines and renin, Kidney Int. 20:92.
Bohr, D. F., 1981, What makes the pressure go up? Hypertension 3(6)II:160.
Blaustein, M. P., 1977, Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment and a hypothesis, Am. J. Physiol. 232:C165.
Rasmussen, H. and Goodman, D. B. P., 1977, Relationships between calcium and cyclic nucleotides in cell activation, Physiol. Rev. 57:421.
Taylor, A. and Windhager, E. E., 1979, Possible role of cytosolic calcium and Na-Ca exchange in regulation of transepithelial sodium transport, Am. J. Physiol. 236:F505.
Arruda, J. A. L. and Sabatini, S., 1980, Cholinergic inhibition of urinary acidification by the turtle bladder, Kidney Int. 17:622.
Humes, H. D., Ichikawa, I., Troy, J. L., and Brenner, B. M., 1978, Evidence for a parathyroid hormone-dependent influence of calcium on the glomerular ultrafiltration coefficient, J.Clin. Invest. 61:32.
Faber, J. L., 1981, The role of calcium in cell death, Life Sci. 29(13):1289.
Studer, R. K. and Borle, A. B., 1979, Effect of pH on the calcium metabolism of isolated rat kidney cells, J.Membr. Biol. 48:325.
Pollak, V. E, Schneider, A. F., Freund, G., and Kark, R. M., 1959, Chronic renal disease with secondary hyperparathyroidism, Arch. Intern. Med. 103:200.
Katz, A. I., Hampers, C. L., Wilson, R. E., Bernstein, D. S., Wachman, A., and Merrill, J. P., 1968, The place of subtotal parathyroidectomy in the management of patients with chronic renal failure, Trans. Am. Soc. Artif Intern. Organs 14:376.
Katz, A. I., Hampers, C. L., and Merrill, J. P., 1969, Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy, Medicine (Baltimore) 48:33.
Kuzela, D. C., Huffer, W. E., Conger, J. D., Winter, S. D., and Hammond, W. S., 1977, Soft tissue calcification in chronic dialysis patients, Am. J. Pathol. 86:403.
Ibels, L. S., Alfrey, A. D., Haut, L., and Huffer, W. E., 1978, Preservation of function in experimental renal disease by dietary restriction of phosphate, N. Engl. J. Med. 298:122.
Karlinsky, M. L., Haut, L., Buddington, B., Schrier, N., and Alfrey, A. D., 1980, Preservation of renal function in experimental glomerulonephritis, Kidney Int. 17:293.
Tomford, R. C., Karlinsky, M. L., Buddington, B., and Alfrey, A. C., 1981, Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis, J. Clin. Invest. 68:655.
Ibels, L. S., Alfrey, A. C., Huffer, W. E., Craswell, P. W., and Weil, R., 1981, Calcification in end-stage kidneys, Am. J. Med. 71:33.
Knochel, J. P., 1981, Serum calcium derangements in rhabdomyolysis, N. Engl. J. Med. 305(3): 161.
Godfraind, T., 1981, Calcium influx and receptor-response coupling, in: New Perspectives on Calcium Antagonism (G. B. Weiss, ed.), The Williams & Wilkins Co., Baltimore, p. 95.
Publicover, S. J., Duncan, C. J., and Smithe, J. L., 1978, The use of A23187 to demonstrate the role of intracellular calcium in causing ultrastructural damage in mammalian muscle, J.Neuropathol. Exp. Neurol. 37:544.
Llach, F., Felsenfel, A. J., and Haussier, M. R., 1981, The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure, N. Engl. J. Med. 305(3):117.
Anderson, R., Haller, R., Elms, J., Carter, N. W., and Knochel, J. P., 1980, Skeletal muscle phosphorus and magnesium deficiency in alcoholic myopathy, J.Miner. Electrol. Metab. 4:106.
Knochel, J. P., Haller, R., and Ferguson, E., 1980, Selective phosphorus deficiency in the hyperalimented hypophosphatemic dog and phosphorylation potentials in the muscle cell, in: Advances in Experimental Medicine and Biology, Volume 128, Phosphate and Minerals in Health and Disease (S. G. Massry, E. Ritz, and A. Jahn, eds.), Plenum Press, New York, p. 323.
Reddy, M. K., Etlinger, J. D., Rabinowitz, M., Fischman, D. A., and Zak, R., 1975, Removal of Z-lines and α-actinin from isolated myofibrils by a calcium-activated neutral protease, J.Biol. Chem. 250:4278.
Ferguson, E. R., Blachley, J., and Knochel, J. P., 1981, Skeletal muscle ionic composition and sodium transport activity in chronic alcoholism, Trans. Assoc. Am. Phys. XCIV:61.
McCarron, D. A., Royer, K. A., Houghton, D. C., and Bennett, W. M., 1980, Chronic tubulointerstitial nephritis caused by recurrent myoglobinuria, Arch. Intern. Med. 140:1106.
Knochel, J. P., 1981, Rhabdomyolysis and myoglobinuria, in: The Kidney in Systemic Disease, 2nd ed., (W. N. Suki and G. Eknoyan, eds.), John Wiley & Sons, New York, p. 263.
Chadha, J. S. and Leviav, A., 1979, Hemolysis, renal failure, and local necrosis following scorpion sting, JAMA 241(10): 1038.
Campos, A., Sibley, R., Kim, Y., Miller, K., and Michael, A. F., 1981, The hemolytic uremic syndrome, Kidney 14(2):23.
Crain, S. M. and Chaoudhury, A. M., 1981, Thrombotic thrombocytopenic purpura (A reappraisal), JAMA 246(11): 1243.
Urizar, R. E., Sherer, G., Fartaglia, A., Pickering, R. J., and Dodds, W. J., 1976, Disseminated intravascular coagulation induced by liquoid in the rat. II. Effect of heparin on hematologic and complement abnormalities and renal lesions studied by light, fluorescence and electron microscopy, Lab. Invest. 34:510.
Moncada, S. and Vane, J. R., 1979, Arachidonic acid metabolites and the interaction between platelets and blood vessel walls, N. Engl. J. Med. 300:1142.
Lyan, E. C. Y., Harkness, D. R., Byrness, J. J., Wallack, H., and Nunez, R., 1979, The presence of platelet aggregating factor in the plasma of patients with TTP and its inhibition by normal plasma, Blood 53:333.
Remuzzi, G., Marchesi, D., Mecca, G., Misiani, R., Livio, M., De Gartano, G., and Donati, M. B., 1978, Hemolytic uremic syndrome: Deficiency of plasma factor(s) regulating prostacyclin activity, Lancet 2:871.
Ridolfi, R. L. and Bell, W. R., 1981, Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature, Medicine 60:413.
Kyle, R. A. and Greipp, P. R., 1980, Smoldering multiple myeloma, Med. Intelligence 302:(24):1347.
Hobbs, J. R., 1967, Papaprotein, benign or malignant? Br. Med. J. 3:699.
Martinez-Maldonado, M. and Garayalde, G., 1981, Renal involvement in multiple myeloma, in: The Kidney in Systemic Disease, 2nd ed. (W. N. Suki and G. Eknoyan, eds.), John Wiley & Sons, New York, p. 197.
Conklin, R. and Alexanian, R., 1975, Clinical classification of plasma cell myeloma, Arch. Intern. Med. 135:149.
Border, W. A. and Cohen, A. H., 1980, Renal biopsy diagnosis of clinically silent multiple myeloma, Ann. Intern. Med. 93(1):43.
Martinez-Maldonado, M., Benabe, J., and Löpez-Novoa, J., Acute renal failure in tubulo interstitial disease including papillary necrosis, in: Acute Renal Failure (B. M. Brenner, J. M. Lazaraus, and B. D. Myeas, eds.), W. B. Saunders Co., Philadelphia, in press.
McGivin, A. R., Hunt, J. S., Day, W. A., and Baily, R. R., 1978, Tamm-Horsfall protein in the glomerular capsular space, J.Clin. Pathol. 31:620.
Carloss, H. W. and Tavassoli, M., 1980, Acute renal failure from precipitation of cryoglobulins in a cool operating room, JAMA 244(13):1472.
Brouet, M. C., Clauvel, J. P., Danon, F., Klein, M., and Seligmann, M., 1974, Biological and clinical significance of cryoglobulins, Am. J. Med. 57:775.
Cordonnier, D., Martin, H., Groslambert, P., Micouin, C., Chenais, F., and Stoebner, P., 1975, Mixed IgM-IgG cryoglobulinemia with glomerulonephritis, Am. J. Med. 59:867.
Meltzer, M., Franklin, E. C., Elias, K., McCluskey, R. T., and Cooper, N., 1966, Cryoglobulinemia: A clinical and laboratory study, Am. J. Med. 40:837.
Golde, D. and Epstein, W., 1969, Mixed cryoglobulins and glomerulonephritis, Ann. Intern. Med. 69:1221.
Beaufils, M. and Morel-Maronger, L., 1978, Pathogenesis of renal disease in monoclonal gammopathies: Current concepts. Nephron 20:125.
Preuss, H. G., Weiss, F. R., and Tammarino, R. M., 1974, Effects on rat kidney slice formation in vitro of proteins from the urine of patients with myelomatosus and nephrosis, Clin. Sci. Mol. Med. 46:283.
Smithline, N., Kassirer, J. P., and Cohen, J. J., 1976, Light-chain nephropathy renal tubular dysfunction associated with light-chain proteinuria, N. Engl. J. Med. 294:71.
McQueen, E. G., 1962, The nature of urinary cast, J.Clin. Pathol. 15:367.
Tubbs, R. R., Gerhardt, G. N., McMahon, J. T., Hall, P. M., Valenzuela, R., and Vidt, D. G., 1981, Light chain nephropathy, Am. J. Med. 71:263.
Baez-Diaz, L. and Martinez-Maldonado, M.: The kidney in paraproteinemic disorder, in: Textbook of Nephrology (S. G. Massry and R.J. Glassock, eds.), Elsevier North-Holland, Inc. New York, in press.
Zlotnick, A. and Rosenmann, E., 1972, Renal pathologic findings associated with monoclonal gammopathies, Arch. Intern. Med. 135:40.
Gallo, G. R., Feiner, H. D., Katz, L. A., Feldman, G. M., Correa, E. B., Chuba, J. V., and Buxbaum, J. N., 1980, Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis, Am. J. Pathol. 99:621.
Tange, T., Karumado, K., Nakazawa, M., Imamura, Y., Kosaka, K., and Kasaoi, A., 1978, Glomerular lesions in multiple myeloma, Acta Pathol. Jpn. 28:325.
Randall, R. R., Williamson, W. C., Jr., Mulinax F., Tung, M. Y., and Still, W. J. S., 1976, Manifestations of systemic light chain deposition, Am. J. Med. 60:293.
Scully, R. E., Galdabini, J. J., and McNeely, B. U., 1981, Case records of the Massachusetts General Hospital, N. Engl. J. Med. 304(1):33.
Heptinstall, R. H., 1974, Amyloidosis, multiple myeloma, Waldenstrom’s macroglobulinemia, mixed IgG-IgM cryoglobulinemia, and benign monoclonal gammopathy, in: Pathology of the Kidney, Volume II (R. H. Heptinstall, ed.), Little, Brown and Company, Boston, p. 737.
Waitzman, M. B., 1979, Proposed metabolic dysfunctions in diabetic microthomboses and microangiopathy, Metabolism 28(4)(Suppl. 1):401.
White, J. G. and Gerrard, J. M., 1977, Prostaglandins and platelet ultrastructure, in: Prostaglandins and Hematology (M. J. Silber, J. B. Smith, and J. J. Locsis, eds.), Spectrum Publications, New York, p. 293.
Smith, J. B., Ingerman, C., Kocsis, J. J., and Silver, M. J., 1974, Formation of an intermediate in prostaglandin Biosynthesis and its association with the platelet release reaction, J.Clin. Invest. 53:1468.
Hamberg, M., Svensson, J., and Samuelsson, B., 1974, Prostaglandin en-doperoxides: A new concept concerning the mode of action and release of prostaglandins, Proc. Natl Acad. Sci. 71:3824.
Waitzman, M. B., Colley, A. M., and Nardelli-Olkowska, K., 1977, Metabolic approaches to studies on diabetic microangiopathy, Diabetes 26:510.
Miller, O. V., Johnson, R. A., and Gorman, R. R., 1977, Inhibition of PGEr stimulated cAMP accumulation in human platelets by thromboxane A2, Prostaglandins 13:599.
Glass, D. B., Gerrard, J. M., Townsend, D., Carr, D., and Goldberg, N. H., 1977, The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation, J. Cyclic Nucleotide Res. 3:37.
Halushka, P. V., Curtis Rogers, R. C., and Boyd Loadholt, C. B., 1981, Increased platelet thromboxane synthesis in diabetes mellitus, J.Lab. Clin. Med. 97(1):87.
Kwaan, H. C., Colwell, J. A., and Suwanwela, N., 1972, Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation, Diabetes 21:108.
Peterson, C. M., Jones, R. L., Koening, R. J., Melvin, E. T., and Lehrman, M., 1977, Reversible hematologic sequelae of diabetes millitus, Ann. Intern. Med. 86:425.
Williamson, J. R. and Kilo, C., 1980, Vascular complications in diabetes mellitus, N. Engl. J. Med. 302(7):399.
Friedman, E. A. and L’Esperance, F. A., Jr., 1980, Diabetic renal-retinal syndrome, Arch. Intern. Med. 140(9): 1149.
Aziz, S., Cohen, A. H., Winer, R. L., Llach, F., and Massry, S. G., 1979, Diabetes mellitus with immune complex glomerulonephritis, Nephron 23:32.
Lauler, D. P., Schreiner, G. E., and David, A., 1960, Renal medullary necrosis, Am. J. Med. 29:132.
Harvald, B. 1963, Renal papillary necrosis: A clinical survey of sixty-six cases, Am. J. Med. 35:481.
Kincaid-Smith, P., 1978, Analgesic nephropathy, Kidney Int. 13:119.
Kincaid-Smith, P., 1979, Analgesic nephropathy in Australia, Contrib. Nephrol. 16:57.
Lindvall, N., 1978, Radiological changes of papillary necrosis, Kidney Int. 13:93.
Kincaid-Smith, P., Nanra, R. S., and Fairley, K. F., 1970, Analgesic Nephropathy: A recoverable form of chronic renal failure, in: Renal Infection and Renal Scarring (P. Kincaid-Smith and K. F. Fairley, eds.), Melbourcen, Mercedes, p. 385.
Wright, J., Morin, L. J., and Dunn, J. L., 1967, Renal papillary necrosis. Eight-year survival of a diabetic, Diabetes 16:664.
Abdulhayoglu, S. and Marble, A., 1964, Necrotizing renal papillitis in diabetes mellitus, Am. J. Med. Sci. 35:623.
Shelley, J. H., 1978, Pharmacological mechanisms of analgesic nephropathy, Kidney Int. 13:15.
Bluemle, L. and Goldberg, M., 1965, Renal accumulation of salicylide and phenacetin: Possible mechanism in the nephropathy of analgesic abuse, J.Clin. Invest. 47:2507.
Abrahams, C., Van Tonder, H., and Hesse, V., 1976, Abnormal vessel in the urinary tract following analgesic abuse in man, Arch. Pathol. Lab. Med. 100:630.
Abrahams, C., Furman, K. I., and Salant, D., 1978, Analgesic abuse and microvascular changes, Am. Heart J. 95:268.
Mihatsch, M. H., Torhorst, J., Amsler, B., and Zollinger, H., 1978, Cap-illosclerosis of the lower urinary tract in analgesic (phenacetin) abuse: An electron microscopic study, Vir chows Arch. Pathol. Anat. Histol. 381:41.
Abrahams, C., Furman, K. I., and Salant, D., 1978, Dermal microangiopathy in patients with analgesic nephropathy, S. Afr. Med. J. 54:393.
Gillenwater, J. Y., 1982, Clinical aspects of urinary tract obstruction, Semin. Nephrol. 2(1):46.
Morrison, A. R., 1982, Alterations in intrarenal hormones in urinary tract obstruction, Semin. Nephrol. 2(1):40.
Gokal, R. and Matthews, D. R., 1977, Renal papillary necrosis after aspirin and alclofenac, Br. Med. J. 2:1517.
Hoffbrand, B. I., 1978, Dapsone and renal papillary necrosis after aspirin and alclofenac. Br. Med. J. 1:78.
Gary, N. E., Dodelson, R., and Eisinger, R. P., 1980, Indomethacin associated acute renal failure, Am. J. Med. 69:135.
Lourie, S. H., Denman, S. J., and Schroeder, E. T., 1977, Association of renal papillary necrosis and ankylosing spondylitis, Arthritis Rheum. 20:917.
Coggins, C. H., 1980, Renal failure in lymphoma, Kidney Int. 17:847.
Goldsweig, H. D., de Champlain, M-L. B., and Davidman, M., 1978, Proximal tubular dysfunction associated with Burkitt’s lymphoma, Cancer 41:568.
Pascal, R. R., 1980, Renal manifestations of extrarenal neoplasms, Human Pathol. 11:7.
Fer, M. F., McKinney, T. D., Richardson, R. L., Hande, K. R., Oldham, R. K., and Greco, F. A., 1981, Cancer and the kidney: Renal complications of neoplasms, Am. J. Med. 71:704.
Tsokos, G. C., Balow, J. E., Spiegel, R. J., and Magrath, I. T., 1981, Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas, Medicine 60:218.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Publishing Corporation
About this chapter
Cite this chapter
Martínez-Maldonado, M., Benabe, J.E., Novello, A. (1983). The Kidney in Systemic Disease. In: Klahr, S., Massry, S.G. (eds) Contemporary Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6722-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6722-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6724-0
Online ISBN: 978-1-4615-6722-6
eBook Packages: Springer Book Archive